FULH.B. Fuller Company

$49.59-15% 1Y

$49.59

$49.0952 weeks$67.21

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though cheap against its own history.

1 good, 2 without data

What the price assumes~+9% a yearderived · Aug 29, 2026

Priced for ~9% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangecheapest in 41 quartersderived

Cheap vs its own history: P/E 13.8 vs a 21.8 median over 41 quarters (−37% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 76% of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

H.B. Fuller Company trades at 13.8× earnings against 31.1× for the median Specialty Chemicals name, cheaper than its own group.

13.8

Trailing P/E · Specialty Chemicals median 31.1 · cheaper than the typical name in its group

Price / sales: 0.75
Price / sales · today's price, trailing year to Aug 29, 2026
Free cash flow yield: 3.8%
Free cash flow yield · Specialty Chemicals median 4.8%
Growth the price implies: +9.5%
Growth the price implies · The price pays for +9.5% free cash flow growth a year for a decade; the business has delivered −29% a year over the last three.

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $3.59 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$68.26
Its own P/E history, median	$78.14
Its own P/E history, upper quartile	$89.85
52-week range	$49.09 – $67.21
Today	$49.59

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.